What Has Biogen Done to Improve the Treatment of Hemophilia?

What has Biogen done to improve the treatment of hemophilia?

Biogen is a company which develops, markets and manufactures therapies for people with rare diseases, including hemophilia.

In 2016, Biogen started it plan to spin off its hemophilia drug business, making it a publicly traded company. In 2017, Biogen announced that it had completed the separation of its global hemophilia business.

Bioverativ, the new company, focuses on the treatments of hemophilia and other blood disorders. It provides major advanced treatments therapies treatment of hemophilia A and B.


Keywords: biogen hemophilia

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.